the pharmacology clinical efficacy adverse effects drug interactions and place in therapy of bitter melon are describedbitter melon momordica charantia is an alternative therapy that has primarily been used for lowering blood glucose levels in patients with diabetes mellituscomponents of bitter melon extract appear to have structural similarities to animal insulinantiviral and antineoplastic activities have also been reported in vitrofour clinical trials found bitter melon juice fruit and dried powder to have a moderate hypoglycemic effectthese studies were small and were not randomized or doubleblind howeverreported adverse effects of bitter melon include hypoglycemic coma and convulsions in children reduced fertility in mice a favismlike syndrome increases in gammaglutamyltransferase and alkaline phosphatase levels in animals and headachesbitter melon may have additive effects when taken with other glucoselowering agentsadequately powered randomized placebocontrolled trials are needed to properly assess safety and efficacy before bitter melon can be routinely recommendedbitter melon may have hypoglycemic effects but data are not sufficient to recommend its use in the absence of careful supervision and monitoring